» Articles » PMID: 22248052

Mechanisms of Yin Yang 1 in Oncogenesis: the Importance of Indirect Effects

Overview
Journal Crit Rev Oncog
Publisher Begell House
Specialty Oncology
Date 2012 Jan 18
PMID 22248052
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Yin Yang 1 (YY1) is a ubiquitously expressed transcription factor that performs numerous functions including transcriptional regulation, cell growth control, apoptosis, large-scale chromosomal dynamics, and X-chromosome inactivation. YY1 clearly is able to control cell functions, including proliferation, by acting as a transcription factor either to activate or repress specific genes. Based on its ability to regulate cell growth control genes, it has been argued that YY1 can function as an oncogene that initiates oncogenesis. Although this is an attractive hypothesis, no reports indicate that YY1 can acutely transform cells in culture or form tumors within animals when overexpressed. Thus, it remains unclear whether YY1 is a "classic" oncogene. However, YY1 controls many diverse cell functions, and these functions may provide clues to its role in oncogenesis. We propose that in many cases YY1 may function in oncogenesis and disease progression through "indirect" effects by virtue of its role in either recruiting Polycomb group proteins to DNA, regulating mutator protein accumulation, controlling large-scale chromosomal dynamics or genomic integrity. Disruption of these functions may causally initiate cancer or may contribute to disease progression. Targeting YY1 functions provides possible avenues for clinical intervention.

Citing Articles

Upregulation of YY1 in M2 macrophages promotes secretion of exosomes containing hsa-circ-0000326 via super-enhancers to facilitate prostate cancer progression.

Guan H, Tao H, Luo J, Wan L, Hu H, Chen L Mol Cell Biochem. 2025; .

PMID: 39960585 DOI: 10.1007/s11010-025-05222-1.


Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications.

Ho M, Bonavida B Cells. 2024; 13(10.

PMID: 38786085 PMC: 11119125. DOI: 10.3390/cells13100864.


The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.

Ullah A, Jiao W, Shen B Cell Mol Biol Lett. 2024; 29(1):73.

PMID: 38745115 PMC: 11094955. DOI: 10.1186/s11658-024-00591-9.


Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma.

Xue T, Lin J, He Y, Li J, Liu Z, Jia Y Heliyon. 2024; 10(2):e24376.

PMID: 38312674 PMC: 10835246. DOI: 10.1016/j.heliyon.2024.e24376.


Role of YY1 in the Regulation of Anti-Apoptotic Gene Products in Drug-Resistant Cancer Cells.

Jung M, Bui I, Bonavida B Cancers (Basel). 2023; 15(17).

PMID: 37686541 PMC: 10486809. DOI: 10.3390/cancers15174267.


References
1.
Chinnappan D, Xiao D, Ratnasari A, Andry C, King T, Weber H . Transcription factor YY1 expression in human gastrointestinal cancer cells. Int J Oncol. 2009; 34(5):1417-23. View

2.
He G, Margolis D . Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol. 2002; 22(9):2965-73. PMC: 133763. DOI: 10.1128/MCB.22.9.2965-2973.2002. View

3.
Valk-Lingbeek M, Bruggeman S, van Lohuizen M . Stem cells and cancer; the polycomb connection. Cell. 2004; 118(4):409-18. DOI: 10.1016/j.cell.2004.08.005. View

4.
Takizawa M, Tolarova H, Li Z, Dubois W, Lim S, Callen E . AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J Exp Med. 2008; 205(9):1949-57. PMC: 2526190. DOI: 10.1084/jem.20081007. View

5.
Moriuchi M, Moriuchi H . YY1 transcription factor down-regulates expression of CCR5, a major coreceptor for HIV-1. J Biol Chem. 2003; 278(15):13003-7. DOI: 10.1074/jbc.M204980200. View